Display Settings:

Format

Send to:

Choose Destination

    Diabetes. 2001 Apr;50(4):763-70.

    Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice.

    Chiu PP, Serreze DV, Danska JS.

    Hospital for Sick Children Research Institute, Department of Surgery, University of Toronto, Ontario, Canada.

    Insulin-dependent diabetes (type 1 diabetes) in the NOD mouse is a T-cell-mediated autoimmune disease. However, B-cells may also play a critical role in disease pathogenesis, as genetically B-cell-deficient NOD mice (NOD.microMT) have been shown to be protected from type 1 diabetes and to display reduced responses to certain islet autoantigens. To examine the requirements for B-cells in the development of type 1 diabetes, we generated a B-cell-naive T-cell repertoire by transplantation of NOD fetal thymuses (FTs) into NOD.scid recipients. Surprisingly, these FT-derived NOD T-cells were diabetogenic in 36% of NOD.scid recipients, despite the absence of B-cells. In addition, T-cells isolated from NOD.microMT mice were diabetogenic in 22% of NOD.scid recipients. Together, these results indicate that B-cells are not an absolute requirement for the generation or effector function of an islet-reactive T-cell repertoire in NOD mice. We suggest that conditions favoring rapid lymphocyte expansion can reveal autoreactive T-cell activity and precipitate disease in genetically susceptible individuals.

    PMID: 11289040 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read